Plain-English translation of NCT06545409 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing a pain-relief technique called a serratus posterior superior intercostal plane block โ a numbing injection guided by ultrasound that targets nerves in your chest wall โ given before robotic surgery to remove your thymus gland. Half of the patients will receive the active numbing medication (bupivacaine), and half will receive a placebo (salt water), so researchers can see if the injection truly reduces pain after surgery. Everyone will also receive standard pain medications after surgery.
Robotic thymus surgery can cause significant chest pain after the operation. Researchers want to know if this targeted nerve block can reduce that pain and help patients recover better, potentially decreasing the amount of strong pain medications needed.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will receive an ultrasound-guided numbing injection in your chest wall 15 minutes before your robotic thymus surgery. After surgery, you will receive standard pain medications and have access to a patient-controlled pump for additional pain relief. You will be asked to rate your pain at 0, 2, 6, 12, and 24 hours after surgery using a simple numbering scale, both while resting and while coughing. At 24 hours after surgery, you will complete a brief questionnaire about your recovery. The study tracks your total pain medication use, any complications, and how long you stay in the hospital.
AI-generated summary from trial data ยท Sep 24, 2026 ยท Not medical advice
Italy